medigraphic.com
SPANISH

Revista Cubana de Pediatría

ISSN 1561-3119 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

Rev Cubana Pediatr 2022; 94 (1)

Mortality from congenital and acquired heart disease in children of Villa Clara province

González OGR, Pedro IE, Carmona PA, Llanes CMC, Anoceto AE, González SA
Full text How to cite this article

Language: Spanish
References: 24
Page: 1-13
PDF size: 494.38 Kb.


Key words:

congenital heart disease, acquired heart disease, mortality.

ABSTRACT

Introduction: Children cardiovascular diseases constitute a heterogeneous group of congenital and acquired conditions that represent an important cause of pediatric morbidity and mortality.
Objective: Describe clinically and epidemiologically pediatric patients who died of cardiovascular diseases between 2005 and 2017.
Methods: A retrospective cross-sectional descriptive study was conducted in the 117 pediatric patients who died with a diagnosis of cardiovascular diseases in the Villa Clara province, between 2005 and 2017, with a predominance of documentary analysis as a research method.
Results: A mortality rate of 1.6 per 1000 live births was obtained, with a tendency to decrease over time, with a predominance of those who died with white skin (70.09%), and without differences in sex. Congenital heart disease (75.21%) was more frequent, such as aortic coarctation and transposition of large vessels. Among the acquired heart diseases, myocarditis was the most frequent (79.30%). 48.70% of patients were diagnosed in the first week of life and 63.25% of patients received medical treatment. The most frequent causes of death were congenital heart disease itself and multi-organ dysfunction due to sepsis in the congenital group and in those acquired cardiogenic shock.
Conclusions: Congenital heart disease predominated, mainly aortic coarctation. Most patients received only medical treatment and the main direct causes of death were congenital heart disease itself and multi-organ dysfunction.


REFERENCES

  1. Aguilar A. Consideraciones sobre la mortalidad infantil y su componente neonatal. Arch argent pediatr. 2016 [acceso 18/01/2021];14(5). Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-00752016000500004&lng=es

  2. Cabral JVB, Guimarães ALS, Sobral Filho DC, Santos ACOd. Mortality due to congenital heart disease in Pernambuco from 1996 to 2016. Rev da Associação Médica Brasileira. 2020 [acceso 18/01/2021];66(7). Disponible en:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000700931&nrm=iso.

  3. Tassinari S, Martínez-Vernaza S, Erazo-Morera N, Pinzón-Arciniegas MC, Gracia G. Epidemiología de las cardiopatías congénitas en Bogotá, Colombia, período comprendido entre 2001 y 2014. ¿Mejorá en la vigilancia o aumento en la prevalencia? Biomédica. 2018 [acceso 18/01/2021];38. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572018000500141&nrm=iso.

  4. Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. Medicine. 2020 [acceso 18/01/2021];99(23). Disponible en: https://pubmed.ncbi.nlm.nih.gov/32502030

  5. Goldstein BH, Petit CJ, Phillips A, Newkirk B. Interventional techniques. In: Wernovsky G, Anderson RH, editors. Anderson's Pediatric Cardiology. Phyladelphya: Elsevier; 2020 [acceso 02/03/2021]:253-80. Disponible en: https://www.clinicalkey.com/#!/content/book/3-s2.0-B9780702076084000248

  6. Liu Y, Chen S, Zühlke L, Babu-Narayan SV, Black GC, Choy M-K, et al. Global prevalence of congenital heart disease in school-age children: a meta-analysis and systematic review. BMC Cardiovasc Disord. 2020 [acceso 02/03/2021];20(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/33213369

  7. Antit S, Bouthouri A, Attia M, Thameur M, Boussabeh E, Zakhama L, et al. Diagnostic characteristics of acute myocarditis. Tunisie medicale. 2019 [acceso 02/03/2021];97(6). Disponible en: https://www.latunisiemedicale.com/article-medicale-tunisie_3591_fr

  8. Ministerio de Salud Pública, Dirección nacional de registros médicos y estadísticas de salud. Anuario Estadístico de Salud, 2016. La Habana: MINSAP; 2017.

  9. Finkelstein J, Duhau M, Speranza A, Marconi É, Escobar P. Evolución de la mortalidad infantil en Argentina en el marco de los Objetivos de Desarrollo del Milenio. Arch argent pediatr. 2016 [acceso 22/01/2021];114(3). Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-00752016000300006&lang=es

  10. Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. Medicine. 2020 [acceso 24/01/2021];99(23). Disponible en: https://journals.lww.com/md-journal/Fulltext/2020/06050/Incidence_and_mortality_trend_of_congenital_heart.68.aspx

  11. Castro Pacheco BL. Evolución de la mortalidad infantil en Cuba. Rev. cuban. pediatr. 2016 [acceso 22/01/2021];88(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312016000100001&lng=es

  12. Egbe A, Uppu S, Stroustrup A, Lee S, Ho D, Srivastava S. Incidences and sociodemographics of specific congenital heart diseases in the United States of America: An evaluation of hospital discharge diagnoses. Pediatr Cardiol. 2014 [acceso 22/01/2021];35(6). Disponible en: http://dx.doi.org/10.1007/s00246-014-0884-8

  13. Pérez-Lescure Picarza J, Mosquera González M, Latasa Zamalloa P, Crespo Marcosa D. Mortalidad de las cardiopatías congénitas en España durante 10 años (2003-2012). An Pediatr. 2017 [acceso 22/01/2021];88(5). Disponible en: http://www.analesdepediatria.org/es/mortalidad-las-cardiopatias-congenitas-espana/avance/S1695403317302217/

  14. Suard C, Flori A, Paoli F, Loundou A, Fouilloux V, Sigaudy S, et al. Accuracy of prenatal screening for congenital heart disease in population: A retrospective study in Southern France. Plos One. 2020;15(10). DOI: https://doi.org/10.1371/journal.pone.0239476

  15. Pfitzer C, Helm PC, Ferentzi H. Changing prevalence of severe congenital heart disease: Results from the National Register for Congenital Heart Defects in Germany. Congenital Heart Dis. 2017 [acceso 22/01/2021];12(6). Disponible en: http://www.techscience.com/chd/v12n6/39224

  16. Singh Y, Tissot C. Echocardiographic Evaluation of Transitional Circulation for the Neonatologists. Front Pediatr. 2018 [acceso 22/01/2021];6(140). Disponible en: https://www.frontiersin.org/article/10.3389/fped.2018.00140

  17. Valentín Rodríguez A, Vidal Talet LA, Perdomo Arrién JC. Caracterización de las cardiopatías congénitas en la provincia de Matanzas. Estudio de trece años. Rev. méd. electrón. 2018 [acceso 22/01/2021];40(5). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242018000501399&nrm=iso.

  18. Pastor-García M, Gimeno-Martos S, Zurriaga Ó, Sorlí JV, Cavero-Carbonell C. Anomalías congénitas cardíacas en la Comunitat Valenciana 2007-2014, el registro poblacional de anomalías congénitas. An Pediatr. 2020 [acceso 22/01/2021];92(1). Disponible en: https://www.analesdepediatria.org/es-anomalias-congenitas-cardiacas-comunitat-valenciana-articulo-S1695403319301687

  19. Salim TR, Soares GP, Klein CH, Oliveira GM. Mortality from Circulatory System Diseases and Malformations in Children in the State of Rio de Janeiro. Arq Brasileiros Cardiol. 2016 [acceso 22/01/2021];106(6). Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016000600464&nrm=iso

  20. Camacho JH, Contreras JP, Díaz PV, Franco JA. Miocarditis en Pediatría. Rev Colombiana Cardiol. 2017 [acceso 22/01/2021];24(5). Disponible en: http://01205633/0000002400000005/v2_201710220703/S0120563317300633/v2_201710220703/es/main.assets

  21. Heymans S, Eriksson U, Lehtonen J, Cooper LT. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. J Am Coll Cardiol. 2016 [acceso 22/01/2021];68(21). Disponible en: https://www.sciencedirect.com/science/article/pii/S0735109716364658

  22. Rao PS. Management of Congenital Heart Disease: State of the Art-Part II-Cyanotic Heart Defects. Children (Basel). 2019 [acceso 22/01/2021];6(4). Disponible en: https://pubmed.ncbi.nlm.nih.gov/30987364

  23. Polo López L, Centella Hernández T, López Menéndez J, Silva Guisasola J. Cirugía de pacientes con cardiopatía congénita en España en el período 2012-2016: registro de intervenciones de la Sociedad Española de Cirugía Torácica-Cardiovascular. Cir Cardiovasc. 2017 [acceso 22/01/2021];24(6). Disponible en: http://www.sciencedirect.com/science/article/pii/S1134009617301936

  24. Torbey AFM, Grippa A. Challenge in the Treatment of Children with Congenital Heart Disease: Reducing Waiting Time for Cardiac Surgery. Internat J Cardiovasc Sci. 2020 [acceso 22/01/2021];33(3). Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472020000300206&nrm=iso




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Pediatr. 2022;94